255 related articles for article (PubMed ID: 27878282)
21. Newcastle Disease Virus Manipulates Mitochondrial MTHFD2-Mediated Nucleotide Metabolism for Virus Replication.
Tang N; Chen P; Zhao C; Liu P; Tan L; Song C; Qiu X; Liao Y; Liu X; Luo T; Sun Y; Ding C
J Virol; 2023 Mar; 97(3):e0001623. PubMed ID: 36794935
[TBL] [Abstract][Full Text] [Related]
22. Methyl-group metabolism and the response of colorectal cancer to 5-fluorouracil.
Iacopetta B
Crit Rev Oncog; 2006 Jul; 12(1-2):115-26. PubMed ID: 17078208
[TBL] [Abstract][Full Text] [Related]
23. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
[TBL] [Abstract][Full Text] [Related]
24. Folate trapping is lethal to cancer cells.
Rather GM
Chem Biol Drug Des; 2023 Dec; 102(6):1588-1591. PubMed ID: 37620162
[TBL] [Abstract][Full Text] [Related]
25. Folate status: effects on pathways of colorectal carcinogenesis.
Choi SW; Mason JB
J Nutr; 2002 Aug; 132(8 Suppl):2413S-2418S. PubMed ID: 12163703
[TBL] [Abstract][Full Text] [Related]
26. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo.
Narayanan S; McConnell J; Little J; Sharp L; Piyathilake CJ; Powers H; Basten G; Duthie SJ
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1436-43. PubMed ID: 15342443
[TBL] [Abstract][Full Text] [Related]
27. Expression and clinical significance of methylenetetrahydrofolate reductase in patients with colorectal cancer.
Odin E; Wettergren Y; Carlsson G; Danenberg PV; Termini A; Willén R; Gustavsson B
Clin Colorectal Cancer; 2006 Jan; 5(5):344-9. PubMed ID: 16512993
[TBL] [Abstract][Full Text] [Related]
28. Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues.
Llanos AA; Dumitrescu RG; Brasky TM; Liu Z; Mason JB; Marian C; Makambi KH; Spear SL; Kallakury BV; Freudenheim JL; Shields PG
Carcinogenesis; 2015 Jan; 36(1):60-7. PubMed ID: 25344837
[TBL] [Abstract][Full Text] [Related]
29. Pairing structural reconstruction with catalytic competence to evaluate the mechanisms of key enzymes in the folate-mediated one-carbon pathway.
Zhao LN; Kaldis P
FEBS J; 2023 May; 290(9):2279-2291. PubMed ID: 35303396
[TBL] [Abstract][Full Text] [Related]
30. How folate metabolism affects colorectal cancer development and treatment; a story of heterogeneity and pleiotropy.
Jennings BA; Willis G
Cancer Lett; 2015 Jan; 356(2 Pt A):224-30. PubMed ID: 24614284
[TBL] [Abstract][Full Text] [Related]
31. Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells.
Green AC; Marttila P; Kiweler N; Chalkiadaki C; Wiita E; Cookson V; Lesur A; Eiden K; Bernardin F; Vallin KSA; Borhade S; Long M; Ghahe EK; Jiménez-Alonso JJ; Jemth AS; Loseva O; Mortusewicz O; Meyers M; Viry E; Johansson AI; Hodek O; Homan E; Bonagas N; Ramos L; Sandberg L; Frödin M; Moussay E; Slipicevic A; Letellier E; Paggetti J; Sørensen CS; Helleday T; Henriksson M; Meiser J
Nat Metab; 2023 Apr; 5(4):642-659. PubMed ID: 37012496
[TBL] [Abstract][Full Text] [Related]
32. Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence.
Hubner RA; Muir KR; Liu JF; Sellick GS; Logan RF; Grainge M; Armitage N; Chau I; Houlston RS
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1607-13. PubMed ID: 16985020
[TBL] [Abstract][Full Text] [Related]
33. Relevance of folate metabolism in the pathogenesis of colorectal cancer.
Ryan BM; Weir DG
J Lab Clin Med; 2001 Sep; 138(3):164-76. PubMed ID: 11528369
[TBL] [Abstract][Full Text] [Related]
34. Crystal Structure of the Emerging Cancer Target MTHFD2 in Complex with a Substrate-Based Inhibitor.
Gustafsson R; Jemth AS; Gustafsson NM; Färnegårdh K; Loseva O; Wiita E; Bonagas N; Dahllund L; Llona-Minguez S; Häggblad M; Henriksson M; Andersson Y; Homan E; Helleday T; Stenmark P
Cancer Res; 2017 Feb; 77(4):937-948. PubMed ID: 27899380
[TBL] [Abstract][Full Text] [Related]
35. MTHFD2--a new twist?
Tedeschi PM; Scotto KW; Kerrigan J; Bertino JR
Oncotarget; 2016 Feb; 7(7):7368-9. PubMed ID: 26848977
[No Abstract] [Full Text] [Related]
36. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer.
Nilsson R; Nicolaidou V; Koufaris C
Gene; 2019 Oct; 716():144032. PubMed ID: 31377316
[TBL] [Abstract][Full Text] [Related]
38. Targeting MTHFD2 to Exploit Cancer-Specific Metabolism and the DNA Damage Response.
Ramos L; Henriksson M; Helleday T; Green AC
Cancer Res; 2024 Jan; 84(1):9-16. PubMed ID: 37922465
[TBL] [Abstract][Full Text] [Related]
39. Aldehyde dehydrogenase homologous folate enzymes: Evolutionary switch between cytoplasmic and mitochondrial localization.
Krupenko NI; Holmes RS; Tsybovsky Y; Krupenko SA
Chem Biol Interact; 2015 Jun; 234():12-7. PubMed ID: 25549576
[TBL] [Abstract][Full Text] [Related]
40. Dietary folate intake in combination with MTHFR C677T genotype and promoter methylation of tumor suppressor and DNA repair genes in sporadic colorectal adenomas.
van den Donk M; van Engeland M; Pellis L; Witteman BJ; Kok FJ; Keijer J; Kampman E
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):327-33. PubMed ID: 17301267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
